Minutes published of UK NSC June 2026 meeting
Minutes published of UK NSC June 2026 meeting
The UK National Screening Committee has published the minutes of its June 2026 meeting.
Feedback invited on UK NSC’s work on screening for coeliac disease
The UK NSC is requesting feedback on screening for coeliac disease, including highlighting issues that would be useful to explore.
Stakeholders provide valuable feedback on breast density and screening evidence
Stakeholders have provided valuable feedback to the UK NSC on breast density and screening evidence.
Consultation opens on evidence relating to population screening for Type 2 diabetes in adults
The UK NSC has opened a public consultation on evidence relating to population screening for Type 2 Diabetes in adults.
Progress made on plans to evaluate SMA newborn screening
Update from latest partnership board meeting overseeing planning of the in-service evaluation of newborn screening for spinal muscular atrophy.
Consultation opens on evidence relating to screening pregnant women for anaemia
The UK NSC has opened a consultation on evidence relating to screening for iron deficiency anaemia in pregnancy.
UK NSC opens consultation on draft prostate cancer screening recommendation
The UK NSC has opened a public consultation on the evidence relating to screening for prostate cancer.
Consultation opens on screening for intimate partner violence
The UK NSC has opened a public consultation on evidence relating to adult and antenatal screening for intimate partner violence.
Consultation opens on antenatal and newborn screening for fragile X syndrome
The UK NSC has opened a consultation on the evidence relating to antenatal and newborn screening for Fragile X syndrome.
UK NSC consults on bladder cancer screening evidence
The UK NSC has opened a public consultation on evidence relation to population screening for bladder cancer.
Consultation opens on population screening for cytomegalovirus
The UK NSC has opened a consultation on evidence relating to antenatal and newborn screening for cytomegalovirus (CMV).
Recent Comments